Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,291Revenue $M269Net Margin (%)-23.2Z-Score11.8
Enterprise Value $M4,936EPS $-0.5Operating Margin %-23.4F-Score5
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-23.2Higher ROA y-yY
Price/Book22.810-y EBITDA Growth Rate %-4.5Quick Ratio4.0Cash flow > EarningsY
Price/Sales18.65-y EBITDA Growth Rate %-16.3Current Ratio4.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-12.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-27.2Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M123ROI % (ttm)-20.8Gross Margin Increase y-yN

Gurus Latest Trades with SGEN

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGENRay Dalio 2014-06-30 Sold Out -0.01%$32.82 - $46.79
($37.8)
$ 42.8613%Sold Out0
SGENRay Dalio 2014-03-31 Buy 0.01%$38.57 - $55.14
($47.61)
$ 42.86-10%New holding, 22400 sh.22,400
SGENPRIMECAP Management 2011-06-30 Add0.05%$15 - $21.34
($17.98)
$ 42.86138%Add 21.21%9,572,853
SGENPRIMECAP Management 2011-03-31 Add0.04%$13.95 - $17.23
($15.41)
$ 42.86178%Add 29.25%7,897,953
SGENPRIMECAP Management 2010-12-31 Add0.06%$13.77 - $17.35
($15.64)
$ 42.86174%Add 77.8%6,110,600
SGENPRIMECAP Management 2010-09-30 Buy 0.09%$11.44 - $15.08
($12.22)
$ 42.86251%New holding, 3436800 sh.3,436,800
SGENJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$9.34 - $12.59
($10.84)
$ 42.86295%Sold Out0
SGENJean-Marie Eveillard 2009-12-31 Buy 0.01%$8.74 - $13.16
($9.69)
$ 42.86342%New holding, 67373 sh.67,373
SGENJean-Marie Eveillard 2009-06-30 Sold Out -0.01%$8.18 - $10.34
($9.08)
$ 42.86372%Sold Out0
SGENJean-Marie Eveillard 2009-03-31 Add$7.23 - $10.36
($9.4)
$ 42.86356%Add 40%70,000
SGENJean-Marie Eveillard 2008-12-31 Buy 0.01%$7.76 - $10.6
($8.9)
$ 42.86382%New holding, 50000 sh.50,000
SGENJean-Marie Eveillard 2008-09-30 Sold Out $8.23 - $12.97
($11)
$ 42.86290%Sold Out0
SGENJean-Marie Eveillard 2008-06-30 Buy $8.79 - $10.59
($9.6)
$ 42.86346%New holding, 60000 sh.60,000
SGENJean-Marie Eveillard 2007-06-30 Sold Out -0.01%$8.48 - $10.41
($9.7)
$ 42.86342%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGEN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SGEN PRIMECAP Management 2014-06-3010,895,8008.850.46-1.01%
SGEN Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


SGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIEGALL CLAY BPresident and CEO 2014-08-12Sell11,200$40.386.14view
BAKER FELIXDirector, 10% Owner 2014-06-13Buy216,595$39.927.36view
SIEGALL CLAY BPresident and CEO 2014-06-10Sell11,200$40.146.78view
BAKER FELIXDirector, 10% Owner 2014-06-09Buy546,252$38.1612.32view
BAKER FELIXDirector, 10% Owner 2014-06-04Buy281,963$34.8622.95view
BAKER FELIXDirector, 10% Owner 2014-05-16Buy189,611$34.0725.8view
BAKER FELIXDirector, 10% Owner 2014-05-09Buy488,382$33.9626.21view
HIMES VAUGHN BEVP, Tech. Ops. & Proc. Sci. 2014-05-09Sell10,000$3522.46view
SIEGALL CLAY BPresident and CEO 2014-04-03Sell5,600$43.34-1.11view
SIEGALL CLAY BPresident and CEO 2014-03-05Sell9,318$52.89-18.96view

Press Releases about SGEN :

    Quarterly/Annual Reports about SGEN:

      News about SGEN:

      Articles On GuruFocus.com
      Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 
      Weekly CFO Sells Highlight: USB, SGEN, CAH, ALXN, ABMD Jul 21 2013 
      Comment for Companies Ranked by Business Predictability Jan 03 2013 
      Weekly CFO Sells Highlight: SGEN, PFIE, MAR, ESRX, LIOX, RGEN Sep 10 2012 
      WEEKLY CFO SELLS HIGHLIGHT: SBAC, XOXO, MTH, FICO, SGEN, OAS Sep 03 2012 
      Weekly CFO Sells Highlight: SWKS, P, SGEN, RT Jun 11 2012 
      5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
      Weekly CFO Sells Highlight: SGEN, APKT, AMRC, FNGN Oct 10 2011 
      Weekly CEO Sells Highlight: WLL, PDE, HUM, SGEN Mar 20 2011 
      Seattle Genetics Inc. (SGEN) President and CEO Clay B Siegall sells 200,000 Shares Mar 18 2011 


      More From Other Websites
      Can the Rally in Seattle Genetics (SGEN) Shares Continue? Aug 18 2014
      SEATTLE GENETICS INC /WA Financials Aug 15 2014
      Seattle Genetics Initiates Phase 1 Clinical Trial of Antibody-Drug Conjugate SGN-CD70A for... Aug 12 2014
      Seattle Genetics Initiates Phase 1 Clinical Trial of Antibody-Drug Conjugate SGN-CD70A for... Aug 12 2014
      SEATTLE GENETICS INC /WA Files SEC form 10-Q, Quarterly Report Aug 08 2014
      Seattle Genetics Up on Narrower-than-Expected Q2 Loss Aug 04 2014
      Seattle Genetics (SGEN) Marked As A Barbarian At The Gate Aug 01 2014
      Seattle Genetics Inc Earnings Call scheduled for 4:30 pm ET today Jul 31 2014
      4:22 pm Seattle Genetics beats by $0.09, beats on revs; Sees FY14 ADCETRIS revs higher than... Jul 31 2014
      SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 31 2014
      Seattle Genetics Reports Second Quarter 2014 Financial Results Jul 31 2014
      Q2 2014 Seattle Genetics Earnings Release - After Market Close Jul 31 2014
      Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) Jul 22 2014
      Seattle Genetics Nearing Key Test for Investor Confidence Jul 16 2014
      3 Stocks Advancing The Health Care Sector Jul 11 2014
      Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2014 Financial... Jul 09 2014
      Seattle Genetics upgraded by UBS Jul 09 2014
      Trade-Ideas: Seattle Genetics (SGEN) Is Today's "Dead Cat Bounce" Stock Jul 09 2014
      Seattle Genetics to Host Conference Call and Webcast Discussion of Second Quarter 2014 Financial... Jul 09 2014
      Seattle Genetics upgraded to Buy from Neutral at UBS Jul 09 2014

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide